Johnson & Johnson to Appeal Jury Verdict in Cosmetic Talc Trial
COVID-19 Update: Your Latest Questions About Johnson & Johnson's Investigational Vaccine Candidate AnsweredDid you like reading this story? Click the heart to show your love.
"I'm a Nurse Who's Also a Healthcare Entrepreneur": Meet the Woman Behind an App Designed to Help Nurses Battle BurnoutDid you like reading this story? Click the heart to show your love.
Did you like reading this story? Click the heart to show your love.
October 27, 2016 – Johnson & Johnson will begin the appeals process after a jury in the Judicial Circuit Court for the City of St. Louis in Missouri returned a verdict today in favor of the plaintiff in a trial involving cosmetic talc.
Statement from Carol Goodrich, spokesperson for Johnson & Johnson Consumer Inc.:
“We deeply sympathize with the women and families impacted by ovarian cancer. We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder. In fact, two cases pending in New Jersey were dismissed in September 2016 by a state court judge who ruled that plaintiffs’ scientific experts could not adequately support their theories that talcum powder causes ovarian cancer, a decision that highlights the lack of credible scientific evidence behind plaintiffs’ allegations.”
For additional information on cosmetic talc, please visit FactsAboutTalc.com.
Media Contact Information